Bipolar disorder: Emotional dysregulation and neuronal vulnerability

CNS Spectrums

Volumn 14, Issue 3, 2009, Pages 122-126

  Stein, Dan J ^a,b   Horn, Neil ^a   Ramesar, Rajkumar ^a   Savitz, Jonathan ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE PREDISPOSITION; EMOTIONAL DISORDER; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPOMANIA; MOOD DISORDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUBSTANCE ABUSE; BRAIN LEVEL; EMOTION; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

BIPOLAR DISORDER; BRAIN CHEMISTRY; EMOTIONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEURONS; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 66849129562     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900020095     Document Type: Article

References (90)

1. Savitz JB, Solms M, Ramesar RS. Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder. Neuromolecular Med. 2005;7:275-286.
2. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38:771-785.
3. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113:1-20.
4. Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93:105-115.
5. Green MJ, Cahill CM, Malhi GS. The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder. J Affect Disord. 2007;103:29-42.
6. Phillips M, Ladouceur C, Drevets W. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13:833-857.
7. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158;1783-1793.
8. Najt P, Perez J, Sanches M, Peluso MA, Glahn D, Soares JC. Impulsivity and bipolar disorder. Eur Neuropsychopharmacol. 2007;17:313-320.
9. Strakowski SM, DelBello MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry. 2005;10:105-116.
10. Lyoo IK, Hwang J, Sim M, Dunn BJ, Renshaw PF. Advances in magnetic resonance imaging methods for the evaluation of bipolar disorder. CNS Spectr. 2006;11:269-280.
11. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev. In press.
12. Schloesser RJ, Huang J, Klein PS, et al. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2007;33:110-133.
13. Kato T. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? Trends Neurosci. 2008;31:495-503.
14. Hassel S, Almeida JRC, Kerr N, et al. Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord. 2008;10:916-927.
15. Foland LC, Altshuler LL, Bookheimer SY, Eisenberger N, Townsend J, Thompson PM. Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res. 2008; 162:27-37.
16. Blumberg HP, Leung HC, Skudlarski P, et al. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry. 2003;60:601-609.
17. McDonald C, Zanelli J, Rabe-Hesketh S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry. 2004;56:411-417.
18. Kempton MJ, Geddes JR, Ettinger U, et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65:1017-1032.
19. Konarski JZ, Mcintyre RS, Kennedy SH, et al. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 2008;10:1-37.
20. Hajek T, Carrey N, Alda M. Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord. 2005;7:393-403.
21. Pfeifer JC, Welge J, Strakowski SM, Adler CM, DelBello MP. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2008;47:1289-1298.
22. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord. 2002;4:105-116.
23. Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:969-995.
24. Quiroz JA, Gray NA, Kato T, et al. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2008;33:2551-2565.
25. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11:851-876.
26. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 2005;10:900-919.
27. Zarate CA, Du J, Quiroz J, et al. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci. 2003;1003:273-291.
28. Berk M, Conus P, Lucas N, et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 2007;9:671-678.
29. Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31:858-873.
30. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32:675-692.
31. Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:209-224.
32. Geyer MA. Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res. 2008;14:71-78.
33. Kato T, Kubota M, Kasahara T. Animal models of bipolar disorder. Neurosci Biobehav Rev. 2007;31:832-842.
34. Elashoff M, Higgs BW, Yolken RH, et al. Meta-analysis of 12 genomic studies in bipolar disorder. J Mol Neurosci. 2007;31:221-243.
35. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci. 2007;61:3-19.
36. Serretti A, Mandelli L. The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. Mol Psychiatry. 2008;13:742-771.
37. Etain B, Henry C, Bellivier F, et al. Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord. 2008;10:867-876.
38. Alloy LB, Abramson LY, Urosevic S, Walshaw PD, Nusslock R, Neeren AM. The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev. 2005;25:1043-1075.
39. Post RM, Leverich GS. The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol. 2006;18:1181-1211.
40. Burton PR, Clayton DG, Cardon LR, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678
41. Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13:558-569.
42. Savitz J, Van Der Merwe L, Stein DJ, et al. Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biol Psychiatry. 2007;62:391-399.
43. Savitz JB, Van Der Merwe L, Stein DJ, et al. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma. Bipolar Disord. 2008;10:49-494.
44. Savitz JB, Ramesar RS. Personality: is it a viable endophenotype for genetic studies of bipolar affective disorder? Bipolar Disord. 2006;8:322-337.
45. Balanza-Martinez V, Rubio C, Selva-Vera G, et al. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev. 2008;32:1426-1438.
46. McDonald C, Bullmore ET, Sham PC, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry. 2004;61:974-984.
47. Frey BN, Walss-Bass C, Stanley JA, et al. Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder. Neuroreport. 2007;18:1567-1570.
48. Chepenik LG, Fredericks C, Papademetris X, et al. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology. 2008 Aug 13. [Epub ahead of print].
49. Shah MP, Wang F, Kalmar JH, et al. Role of variation in the serotonin transporter protein gene (SLC6A4) in trait disturbances in the ventral anterior cingulate in bipolar disorder. Neuropsychopharmacology. 2008 Nov 26. [Epub ahead of print].
50. Gardner, R. Mechanisms in manic-depressive disorder: an evolutionary model. Arch Gen Psychiatry. 1982;39:1436-1441.
51. Brody JF. Evolutionary recasting: ADHD, mania and its variants. J Affect Disord. 2001;65:197-215.
52. Keller MC, Miller G. Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav Brain Sci. 2006;29:385-404.
53. Bowden CL. Bipolar pathophysiology and development of improved treatments. Brain Res. 2008;1235:92-97.
54. Patten SB, Paris J. The bipolar spectrum - a bridge too far? Can J Psychiatry. 2008;53:762-768.
55. Ghaemi SN, Bauer M, Cassidy F, et al. Diagnostic guidelines for bipolar disorder: a summary of the International society for bipolar disorders diagnostic guidelines task force report. Bipolar Disord. 2008;10:117-128.
56. Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007;33:886-892.
57. Phillips ML, Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull. 2007;33:893-904.
58. Fajutrao L, Locklear JC, Priaulx J, et al. A systematic review on the epidemiology and socioeconomic burden of bipolar disorder in Europe. Value Health. 2008;11:A580-A581.
59. Hawton K, Sutton L, Haw C, et al. Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J Clin Psychiatry. 2005;66:693-704.
60. Allen R, Smith DJ. Screening for bipolar disorder: strengths and limitations of currently available instruments. Prim Care Community Psychiatr. 2008;13:47-51.
61. Picardi A. Rating scales in bipolar disorder. Curr Opin Psychiatry. 2009;22:42-49.
62. Tohen M, Bowden C, Calabrese J, et al. The international society of bipolar disorders task force on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2008;10:1.
63. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293:2528-2530.
64. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005;58:175-189.
65. Mcintyre RS, Soczynska JK, Beyer JL, et al. Medical comorbidity in bipolar disorder: reprioritizing unmet needs. Curr Opin Psychiatry. 2007;20:406-416.
66. Leibenluft E, Rich BA. Pediatric bipolar disorder. Ann Rev Clin Psychol. 2008;4:163-187.
67. Ghaemi SN, Martin A. Defining the boundaries of childhood bipolar disorder. Am J Psychiatry. 2007;164:185-188.
68. Fountoulakis KN, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86:1-10.
69. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trialls. Am J Psychiatry. 2004;161:217-222.
70. Kleindienst N, Engel RR, Greil W. Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders. Bipolar Disord. 2005;7:404-417.
71. Severus WE, Kleindienst N, Seemuller F, et al. What is the optimal serum lithium level in the long-term treatment of bipolar disorder: a review? Bipolar Disord. 2008;10:231237.
72. Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry. 2007;7:40.
73. Smith LA, Cornelius V, Warnock A, et al. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord. 2007;9:551-560.
74. Smith LA, Cornelius V, Warnock A, et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord. 2007;9:394-412.
75. Smith LA, Cornelius V, Warnock A, et al. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand. 2007;115:12-20.
76. Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol. 2008;11:999-1029.
77. Ghaemi SN, Pardo TB, Hsu DJ. Strategies for preventing the recurrence of bipolar disorder. J Clin Psychiatry. 2004;65:16-23.
78. Ghaemi SN, Wingo AP, Filkowski MA, et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand. 2008;118:347-356.
79. Andreescu C, Mulsanta BH, Emanuel JE. Complementary and alternative medicine in the treatment of bipolar disorder: a review of the evidence. J Affect Disord. 2008;110:16-26.
80. Montgomery P, Richardson AJ. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005169.
81. Mathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008;33:2080-2092.
82. Stein DJ. Emotional regulation: implications for the psychobiology of psychotherapy. CNS Spectr. 2008;13:195-198.
83. Miklowitz DJ, Johnson SL. The psychopathology and treatment of bipolar disorder. Ann Rev Clin Psychol. 2006;2:199-235.
84. Beynon S, Soares-Weiser K, Woolacott N, et al. Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry. 2008;192:5-11.
85. Justo LP, Soares BGO, Calil HM. Family interventions for bipolar disorder. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005167.
86. Rouget BW, Aubry JM. Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature. J Affect Disord. 2007;98:11-27.
87. Morriss RK, Faizal MA, Jones AP, et al. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004854.
88. Sajatovic M, Chen PJ, Dines P, et al. Psychoeducational approaches to medication adherence in patients with bipolar disorder. Disease Management & Health Outcomes. 2007;15:181-192.
89. Gaudiano BA, Weinstock LA, Miller IW. Improving treatment adherence in bipolar disorder - a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif. 2008;32:267-301.
90. Berk M, Hallam K, Lucas N, et al. Early intervention in bipolar disorders: opportunities and pitfalls. Med J Aust. 2007;187(7 suppl):S11-S14.